Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett's Esophagus
Stock Information for Interpace Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.